Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
24
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Elia Marc | Director | 4 | $0 | $0 | 2023-06-14 |
| Jensen Klavs F. | Director | 8 | $50.4K | $0 | 2023-06-14 |
| Garg Pushkal | Director | 4 | $0 | $0 | 2023-06-14 |
| Coulie Bernard | Director | 3 | $0 | $0 | 2023-06-14 |
| SCHEGERIN MARC | Director | 4 | $0 | $0 | 2023-06-14 |
| BOLNO PAUL | Director | 4 | $0 | $0 | 2023-06-14 |
| Srivastava Sapna | Director | 4 | $0 | $0 | 2023-06-14 |
| VINK PATRICK V.J.J. | Director | 3 | $0 | $0 | 2023-06-14 |
| SCHULMAN AMY W | Director, 10% Owner | 29 | $4.04M | $0 | 2023-06-14 |
| Warren Marshelle Smith | Chief Medical Officer | 2 | $0 | $0 | 2023-01-24 |
| Capasso Richard | See Remarks | 4 | $0 | $3.9K | 2023-01-24 |
| First David | Chief People Officer | 4 | $0 | $0 | 2023-01-24 |
| Knopf Lawrence J | General Counsel | 6 | $0 | $0 | 2023-01-24 |
| BERNSTEIN HOWARD PHD MD | Interim Chief Executive Office | 4 | $0 | $0 | 2023-01-24 |
| Zajic Micah | Chief Financial Officer | 5 | $0 | $0 | 2022-07-11 |
| Sharei Armon | President and CEO | 13 | $0 | $0 | 2022-06-30 |
| Loxam Teri | Chief Financial Officer | 2 | $0 | $0 | 2021-02-23 |
| Rosen Oliver | Chief Medical Officer | 2 | $0 | $0 | 2021-02-23 |
| AMERICAN INTERNATIONAL GROUP INC | 10% Owner | 14 | $20.00M | $0 | 2020-11-03 |
| Amy Schulman, as Trustee The Armon R. Sharei Irrevocable GST Trust of 2016, U/D/T Dated December 29, 2016 | 10% Owner | 3 | $0 | $0 | 2020-11-03 |
| Artal Treasury Ltd | 10% Owner | 4 | $7.44M | $0 | 2020-11-03 |
| Polaris Partners VII, L.P. | 10% Owner | 12 | $4.00M | $0 | 2020-11-03 |
| Temasek Holdings (Private) Ltd | 10% Owner | 3 | $10.00M | $0 | 2020-11-03 |
| Moessinger Eric | Director | 1 | $0 | $0 | 2020-10-29 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| BOLNO PAUL | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 39,875 | — | $0 | 39,875 | SEC↗ |
| Coulie Bernard | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 39,875 | — | $0 | 39,875 | SEC↗ |
| Elia Marc | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 39,875 | — | $0 | 39,875 | SEC↗ |
| Garg Pushkal | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 39,875 | — | $0 | 39,875 | SEC↗ |
| Jensen Klavs F. | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 39,875 | — | $0 | 39,875 | SEC↗ |
| SCHEGERIN MARC | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 39,875 | — | $0 | 39,875 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | A Award deriv | 2023-06-14 | 2023-06-15 | 39,875 | — | $0 | 39,875 | SEC↗ |
| Srivastava Sapna | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 39,875 | — | $0 | 39,875 | SEC↗ |
| VINK PATRICK V.J.J. | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 39,875 | — | $0 | 39,875 | SEC↗ |
| BERNSTEIN HOWARD PHD MD | Interim Chief Executive Offi | A Award deriv | 2023-01-24 | 2023-01-26 | 830,000 | — | $0 | 830,000 | SEC↗ |
| First David | Chief People Officer | A Award deriv | 2023-01-24 | 2023-01-26 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Knopf Lawrence J | General Counsel | A Award deriv | 2023-01-24 | 2023-01-26 | 227,000 | — | $0 | 227,000 | SEC↗ |
| Warren Marshelle Smith | Chief Medical Officer | A Award deriv | 2023-01-24 | 2023-01-26 | 261,000 | — | $0 | 261,000 | SEC↗ |
| Capasso Richard | See Remarks | A Award deriv | 2023-01-24 | 2023-01-26 | 213,000 | — | $0 | 213,000 | SEC↗ |
| Capasso Richard | See Remarks | S Sale | 2022-08-15 | 2022-08-16 | 1,183 | $3.33 | $3.9K | 0 | SEC↗ |
| Zajic Micah | Chief Financial Officer | A Award deriv | 2022-07-11 | 2022-07-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Capasso Richard | See Remarks | A Award | 2022-06-30 | 2022-07-05 | 1,183 | $2.70 | $3.2K | 1,183 | SEC↗ |
| Knopf Lawrence J | General Counsel | A Award | 2022-06-30 | 2022-07-05 | 1,484 | $2.70 | $4.0K | 1,938 | SEC↗ |
| Sharei Armon | President and CEO | A Award | 2022-06-30 | 2022-07-05 | 2,436 | $2.70 | $6.6K | 287,884 | SEC↗ |
| Coulie Bernard | Director | A Award deriv | 2022-06-15 | 2022-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Elia Marc | Director | A Award deriv | 2022-06-15 | 2022-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SCHEGERIN MARC | Director | A Award deriv | 2022-06-15 | 2022-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Jensen Klavs F. | Director | A Award deriv | 2022-06-15 | 2022-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Srivastava Sapna | Director | A Award deriv | 2022-06-15 | 2022-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VINK PATRICK V.J.J. | Director | A Award deriv | 2022-06-15 | 2022-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BOLNO PAUL | Director | A Award deriv | 2022-06-15 | 2022-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Garg Pushkal | Director | A Award deriv | 2022-06-15 | 2022-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | A Award deriv | 2022-06-15 | 2022-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Warren Marshelle Smith | Chief Medical Officer | A Award deriv | 2022-06-01 | 2022-06-03 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Jensen Klavs F. | Director | P Buy | 2022-05-25 | 2022-05-27 | 14,326 | $3.52 | $50.4K | 353,309 | SEC↗ |
| BERNSTEIN HOWARD PHD MD | Chief Scientific Officer | A Award deriv | 2022-02-10 | 2022-02-15 | 195,000 | — | $0 | 195,000 | SEC↗ |
| Sharei Armon | President and CEO | A Award deriv | 2022-02-10 | 2022-02-15 | 395,000 | — | $0 | 395,000 | SEC↗ |
| Knopf Lawrence J | General Counsel | A Award deriv | 2022-02-10 | 2022-02-15 | 97,000 | — | $0 | 97,000 | SEC↗ |
| Capasso Richard | See Remarks | A Award deriv | 2022-02-10 | 2022-02-15 | 42,000 | — | $0 | 42,000 | SEC↗ |
| First David | Chief People Officer | A Award deriv | 2022-02-10 | 2022-02-15 | 66,000 | — | $0 | 66,000 | SEC↗ |
| Zajic Micah | Chief Business Officer | A Award deriv | 2022-02-10 | 2022-02-15 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Sharei Armon | President and CEO | M Exercise deriv | 2022-01-12 | 2022-01-13 | 13,000 | $1.81 | $23.5K | 171,937 | SEC↗ |
| Sharei Armon | President and CEO | M Exercise | 2022-01-12 | 2022-01-13 | 13,000 | $1.81 | $23.5K | 285,448 | SEC↗ |
| Knopf Lawrence J | General Counsel | A Award | 2021-12-31 | 2022-01-04 | 454 | $7.59 | $3.4K | 454 | SEC↗ |
| Sharei Armon | President and CEO | A Award | 2021-12-31 | 2022-01-04 | 1,686 | $7.59 | $12.8K | 272,448 | SEC↗ |
| Sharei Armon | President and CEO | M Exercise deriv | 2021-12-22 | 2021-12-22 | 11,049 | — | $0 | 184,937 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | M Exercise deriv | 2021-12-22 | 2021-12-23 | 6,581 | — | $0 | 3,949 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | M Exercise deriv | 2021-12-22 | 2021-12-23 | 7,458 | — | $0 | 3,072 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | M Exercise deriv | 2021-12-22 | 2021-12-23 | 10,091 | — | $0 | 439 | SEC↗ |
| Sharei Armon | President and CEO | M Exercise | 2021-12-22 | 2021-12-22 | 11,049 | $1.81 | $20.0K | 270,762 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | M Exercise | 2021-12-22 | 2021-12-23 | 7,458 | $4.59 | $34.2K | 208,233 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | M Exercise | 2021-12-22 | 2021-12-23 | 6,581 | $4.59 | $30.2K | 214,814 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | M Exercise | 2021-12-22 | 2021-12-23 | 10,091 | $2.02 | $20.4K | 200,775 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | P Buy | 2021-12-13 | 2021-12-15 | 1,850 | $10.94 | $20.2K | 1,850 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | P Buy | 2021-12-13 | 2021-12-15 | 1,850 | $10.88 | $20.1K | 1,850 | SEC↗ |
| Coulie Bernard | Director | A Award deriv | 2021-07-01 | 2021-07-01 | 21,000 | — | $0 | 21,000 | SEC↗ |
| VINK PATRICK V.J.J. | Director | A Award deriv | 2021-07-01 | 2021-07-01 | 21,000 | — | $0 | 21,000 | SEC↗ |
| BOLNO PAUL | Director | A Award deriv | 2021-06-15 | 2021-06-17 | 10,500 | — | $0 | 10,500 | SEC↗ |
| Jensen Klavs F. | Director | A Award deriv | 2021-06-15 | 2021-06-17 | 10,500 | — | $0 | 10,500 | SEC↗ |
| Srivastava Sapna | Director | A Award deriv | 2021-06-15 | 2021-06-17 | 10,500 | — | $0 | 10,500 | SEC↗ |
| Garg Pushkal | Director | A Award deriv | 2021-06-15 | 2021-06-17 | 10,500 | — | $0 | 10,500 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | A Award deriv | 2021-06-15 | 2021-06-17 | 10,500 | — | $0 | 10,500 | SEC↗ |
| SCHEGERIN MARC | Director | A Award deriv | 2021-06-15 | 2021-06-17 | 10,500 | — | $0 | 10,500 | SEC↗ |
| Elia Marc | Director | A Award deriv | 2021-06-15 | 2021-06-17 | 10,500 | — | $0 | 10,500 | SEC↗ |
| Sharei Armon | President and CEO | M Exercise deriv | 2021-02-27 | 2021-03-02 | 8,000 | — | $0 | 195,986 | SEC↗ |
| Sharei Armon | President and CEO | M Exercise | 2021-02-27 | 2021-03-02 | 8,000 | $1.81 | $14.5K | 259,713 | SEC↗ |
| Sharei Armon | President and CEO | A Award deriv | 2021-02-23 | 2021-02-25 | 195,000 | — | $0 | 195,000 | SEC↗ |
| Loxam Teri | Chief Financial Officer | A Award deriv | 2021-02-23 | 2021-02-25 | 75,950 | — | $0 | 75,950 | SEC↗ |
| BERNSTEIN HOWARD PHD MD | Chief Scientific Officer | A Award deriv | 2021-02-23 | 2021-02-25 | 72,900 | — | $0 | 72,900 | SEC↗ |
| First David | Chief People Officer | A Award deriv | 2021-02-23 | 2021-02-25 | 28,900 | — | $0 | 28,900 | SEC↗ |
| Rosen Oliver | Chief Medical Officer | A Award deriv | 2021-02-23 | 2021-02-25 | 75,625 | — | $0 | 75,625 | SEC↗ |
| Zajic Micah | Chief Business Officer | A Award deriv | 2021-02-23 | 2021-02-25 | 22,339 | — | $0 | 22,339 | SEC↗ |
| Knopf Lawrence J | General Counsel | A Award deriv | 2021-02-23 | 2021-02-25 | 48,100 | — | $0 | 48,100 | SEC↗ |
| Sharei Armon | President and CEO | M Exercise deriv | 2021-01-08 | 2021-01-12 | 2,500 | — | $0 | 203,986 | SEC↗ |
| Sharei Armon | President and CEO | M Exercise | 2021-01-08 | 2021-01-12 | 2,500 | $1.81 | $4.5K | 251,713 | SEC↗ |
| Amy Schulman, as Trustee The A | 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 7,016 | — | $0 | 0 | SEC↗ |
| Amy Schulman, as Trustee The A | 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 3,453 | — | $0 | 0 | SEC↗ |
| Artal Treasury Ltd | 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 843,490 | — | $0 | 0 | SEC↗ |
| Artal Treasury Ltd | 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 240,375 | — | $0 | 0 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 168,698 | — | $0 | 0 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 56,462 | — | $0 | 0 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 412,608 | — | $0 | 0 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 28,863 | — | $0 | 0 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 348,725 | — | $0 | 0 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 93,279 | — | $0 | 0 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 630,672 | — | $0 | 0 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 44,120 | — | $0 | 0 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 807,096 | — | $0 | 0 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 24,396 | — | $0 | 0 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 21,087 | — | $0 | 0 | SEC↗ |
| Polaris Partners VII, L.P. | 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 28,863 | — | $0 | 0 | SEC↗ |
| Polaris Partners VII, L.P. | 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 412,608 | — | $0 | 0 | SEC↗ |
| Polaris Partners VII, L.P. | 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 56,462 | — | $0 | 0 | SEC↗ |
| Polaris Partners VII, L.P. | 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 807,096 | — | $0 | 0 | SEC↗ |
| Polaris Partners VII, L.P. | 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 44,120 | — | $0 | 0 | SEC↗ |
| Polaris Partners VII, L.P. | 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 630,672 | — | $0 | 0 | SEC↗ |
| Polaris Partners VII, L.P. | 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 348,725 | — | $0 | 0 | SEC↗ |
| Polaris Partners VII, L.P. | 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-03 | 24,397 | — | $0 | 0 | SEC↗ |
| Jensen Klavs F. | Director | C Conversion deriv | 2020-11-03 | 2020-11-03 | 6,908 | — | $0 | 0 | SEC↗ |
| Jensen Klavs F. | Director | C Conversion deriv | 2020-11-03 | 2020-11-03 | 7,017 | — | $0 | 0 | SEC↗ |
| AMERICAN INTERNATIONAL GROUP I | 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-04 | 1,435,079 | — | $0 | 0 | SEC↗ |
| AMERICAN INTERNATIONAL GROUP I | 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-04 | 36,937 | — | $0 | 0 | SEC↗ |
| AMERICAN INTERNATIONAL GROUP I | 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-04 | 66,803 | — | $0 | 0 | SEC↗ |
| Temasek Holdings (Private) Ltd | 10% Owner | C Conversion deriv | 2020-11-03 | 2020-11-05 | 1,888,924 | — | $0 | 0 | SEC↗ |
| Amy Schulman, as Trustee The A | 10% Owner | C Conversion | 2020-11-03 | 2020-11-03 | 11,025 | — | $0 | 385,891 | SEC↗ |
| Artal Treasury Ltd | 10% Owner | C Conversion | 2020-11-03 | 2020-11-03 | 1,141,308 | — | $0 | 1,141,308 | SEC↗ |
| Artal Treasury Ltd | 10% Owner | P Buy | 2020-11-03 | 2020-11-03 | 465,000 | $16.00 | $7.44M | 1,606,308 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | C Conversion | 2020-11-03 | 2020-11-03 | 2,315,652 | — | $0 | 2,315,652 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | C Conversion | 2020-11-03 | 2020-11-03 | 161,994 | — | $0 | 161,994 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | C Conversion | 2020-11-03 | 2020-11-03 | 22,204 | — | $0 | 190,684 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | P Buy | 2020-11-03 | 2020-11-03 | 16,346 | $16.00 | $261.5K | 178,340 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | P Buy | 2020-11-03 | 2020-11-03 | 233,654 | $16.00 | $3.74M | 2,549,306 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | C Conversion | 2020-11-03 | 2020-11-03 | 275,860 | — | $0 | 275,860 | SEC↗ |
| Polaris Partners VII, L.P. | 10% Owner | C Conversion | 2020-11-03 | 2020-11-03 | 161,994 | — | $0 | 161,994 | SEC↗ |
| Polaris Partners VII, L.P. | 10% Owner | C Conversion | 2020-11-03 | 2020-11-03 | 2,315,652 | — | $0 | 2,315,652 | SEC↗ |
| Polaris Partners VII, L.P. | 10% Owner | P Buy | 2020-11-03 | 2020-11-03 | 233,654 | $16.00 | $3.74M | 2,549,306 | SEC↗ |
| Polaris Partners VII, L.P. | 10% Owner | P Buy | 2020-11-03 | 2020-11-03 | 16,346 | $16.00 | $261.5K | 178,340 | SEC↗ |
| Jensen Klavs F. | Director | C Conversion | 2020-11-03 | 2020-11-03 | 14,662 | — | $0 | 338,982 | SEC↗ |
| AMERICAN INTERNATIONAL GROUP I | 10% Owner | C Conversion | 2020-11-03 | 2020-11-04 | 1,511,139 | — | $0 | 1,511,139 | SEC↗ |
| AMERICAN INTERNATIONAL GROUP I | 10% Owner | C Conversion | 2020-11-03 | 2020-11-04 | 38,895 | — | $0 | 38,895 | SEC↗ |
| AMERICAN INTERNATIONAL GROUP I | 10% Owner | C Conversion | 2020-11-03 | 2020-11-04 | 70,344 | — | $0 | 70,344 | SEC↗ |
| AMERICAN INTERNATIONAL GROUP I | 10% Owner | P Buy | 2020-11-03 | 2020-11-04 | 625,000 | $16.00 | $10.00M | 625,000 | SEC↗ |
| Temasek Holdings (Private) Ltd | 10% Owner | P Buy | 2020-11-03 | 2020-11-05 | 625,000 | $16.00 | $10.00M | 2,513,924 | SEC↗ |
| Temasek Holdings (Private) Ltd | 10% Owner | C Conversion | 2020-11-03 | 2020-11-05 | 1,888,924 | — | $0 | 1,888,924 | SEC↗ |
| AMERICAN INTERNATIONAL GROUP I | 10% Owner | C Conversion deriv | 2020-10-30 | 2020-11-02 | 66,803 | — | $0 | 0 | SEC↗ |
| AMERICAN INTERNATIONAL GROUP I | 10% Owner | C Conversion deriv | 2020-10-30 | 2020-11-02 | 1,435,079 | — | $0 | 0 | SEC↗ |
| AMERICAN INTERNATIONAL GROUP I | 10% Owner | C Conversion deriv | 2020-10-30 | 2020-11-02 | 36,937 | — | $0 | 0 | SEC↗ |
| AMERICAN INTERNATIONAL GROUP I | 10% Owner | C Conversion | 2020-10-30 | 2020-11-02 | 38,895 | — | $0 | 38,895 | SEC↗ |
| AMERICAN INTERNATIONAL GROUP I | 10% Owner | C Conversion | 2020-10-30 | 2020-11-02 | 70,344 | — | $0 | 70,344 | SEC↗ |
| AMERICAN INTERNATIONAL GROUP I | 10% Owner | P Buy | 2020-10-30 | 2020-11-02 | 625,000 | $16.00 | $10.00M | 625,000 | SEC↗ |
| AMERICAN INTERNATIONAL GROUP I | 10% Owner | C Conversion | 2020-10-30 | 2020-11-02 | 1,511,139 | — | $0 | 1,511,139 | SEC↗ |
| Zajic Micah | Chief Business Officer | A Award deriv | 2020-10-29 | 2021-04-01 | 32,643 | — | $0 | 32,643 | SEC↗ |
| Sharei Armon | President and CEO | A Award deriv | 2020-10-29 | 2020-10-30 | 105,300 | — | $0 | 105,300 | SEC↗ |
| Srivastava Sapna | Director | A Award deriv | 2020-10-29 | 2020-10-30 | 42,120 | — | $0 | 42,120 | SEC↗ |
| SCHULMAN AMY W | Director, 10% Owner | A Award deriv | 2020-10-29 | 2020-10-30 | 7,055 | — | $0 | 7,055 | SEC↗ |
| First David | Chief People Officer | A Award deriv | 2020-10-29 | 2020-10-30 | 53,703 | — | $0 | 53,703 | SEC↗ |
| Elia Marc | Director | A Award deriv | 2020-10-29 | 2020-10-30 | 7,055 | — | $0 | 7,055 | SEC↗ |
| Rosen Oliver | Chief Medical Officer | A Award deriv | 2020-10-29 | 2020-10-30 | 10,530 | — | $0 | 10,530 | SEC↗ |
| Zajic Micah | Chief Business Officer | A Award deriv | 2020-10-29 | 2020-10-30 | 32,643 | — | $0 | 32,643 | SEC↗ |
| BOLNO PAUL | Director | A Award deriv | 2020-10-29 | 2020-10-30 | 7,055 | — | $0 | 7,055 | SEC↗ |
| BERNSTEIN HOWARD PHD MD | Chief Scientific Officer | A Award deriv | 2020-10-29 | 2020-10-30 | 10,530 | — | $0 | 10,530 | SEC↗ |
| SCHEGERIN MARC | Director | A Award deriv | 2020-10-29 | 2020-10-30 | 42,120 | — | $0 | 42,120 | SEC↗ |
| Loxam Teri | Chief Financial Officer | A Award deriv | 2020-10-29 | 2020-10-30 | 10,530 | — | $0 | 10,530 | SEC↗ |
| Knopf Lawrence J | General Counsel | A Award deriv | 2020-10-29 | 2020-10-30 | 77,922 | — | $0 | 77,922 | SEC↗ |
| Garg Pushkal | Director | A Award deriv | 2020-10-29 | 2020-10-30 | 7,055 | — | $0 | 7,055 | SEC↗ |
| Jensen Klavs F. | Director | A Award deriv | 2020-10-29 | 2020-10-30 | 7,055 | — | $0 | 7,055 | SEC↗ |
| Moessinger Eric | Director | A Award deriv | 2020-10-29 | 2020-10-30 | 7,055 | — | $0 | 7,055 | SEC↗ |